In late November Abbott—one of Dexcom’s main competitors— recalled some of its CGMs due to inaccurate low glucose readings.
DexCom has had a rough ride this year. The medical technology company is grappling with concerns about its slowing growth and allegations of faulty blood glucose monitors. However, DexCom is “already ...
Diabeloop announced today that its DBLG2 algorithm for automated insulin delivery has received FDA 510(k) clearance.
This device from SwitchBot measures temperature, humidity, carbon dioxide levels and more to keep my home safe during the ...
Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a public ...
LOS ANGELES, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) for violations of §§10(b) ...
Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may provide false low glucose readings. Hundreds of adverse events and seven ...
DexCom has been in for a rough ride this year. The medical technology company is grappling with concerns over its slowing growth and allegations of faulty blood glucose monitors.